Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.56 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.56 |
| ▸ | TSHR | P16473 | 1/20 | 0.56 |
| ▸ | GABRA1 | P14867 | 2/20 | 0.48 |
| ▸ | GABRB1 | P18505 | 2/20 | 0.48 |
| ▸ | GABRA2 | P47869 | 1/20 | 0.48 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.48 |
| ▸ | SELL | P14151 | 2/20 | 0.47 |
| ▸ | SELP | P16109 | 2/20 | 0.47 |
| ▸ | SELE | P16581 | 1/20 | 0.47 |
| ▸ | PTPN1 | P18031 | 3/20 | 0.43 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.41 |
| ▸ | CA1 | P00915 | 2/20 | 0.41 |
| ▸ | CA2 | P00918 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 2/20 | 0.41 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | CA6 | P23280 | 2/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL69509 | 0.84 | CYP3A4 (0.72) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL2050124 | 0.82 | CYP3A4 (0.46) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL12189844 | 0.80 | CYP3A4 (0.43) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL16599884 | 0.80 | TSHR (0.43) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL7520723 | 0.79 | CYP3A4 (0.47) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL25012039 | 0.76 | CYP3A4 (0.45) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL6541836 | 0.76 | ERN1 (0.60) | CYP3A4ALOX15ALDH1A1CA1CA2 | |
| SCHEMBL8285504 | 0.74 | AKR1C3 (0.69) | TDP1CYP3A4TSHRSELLSELP | |
| SCHEMBL6542408 | 0.74 | PTPN1 (0.41) | TDP1CYP3A4TSHRGABRA1GABRB1 | |
| SCHEMBL16595415 | 0.74 | CYP3A4 (0.39) | TDP1CYP3A4TSHRGABRA1GABRB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025262615-A1 | ANTIOXIDANTS CONTAINING DIAZIRINE FUNCTIONALITIES, COMPOSITIONS COMPRISING THEM AND USE THEREOF | BELLARE ANUJ (US) | 2025-12-26 | — | — | WO | claimed |
| CN-119708346-A | Polymer, preparation method thereof, retarder and oil well cement paste | 中国石油天然气集团有限公司 | 2025-03-28 | — | — | CN | claimed |
| CN-114351440-A | Nano composite antibacterial non-woven fabric and preparation process and application thereof | 广东宝创环保新材料制品有限公司 | 2022-04-15 | — | — | CN | claimed |
| WO-2025262615-A1 | ANTIOXIDANTS CONTAINING DIAZIRINE FUNCTIONALITIES, COMPOSITIONS COMPRISING THEM AND USE THEREOF | BELLARE ANUJ (US) | 2025-12-26 | — | — | WO | disclosed |
| EP-4621028-A1 | FLUORESCENCE RECOVERY IN NANOGRAPHENE | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2025-09-24 | — | — | EP | disclosed |
| CN-120082284-A | UV skin-feel coating for nursing products, preparation method and application thereof | 金桥德克新材料股份有限公司 | 2025-06-03 | — | — | CN | disclosed |
| CN-115745885-B | Chiral liquid crystal fluorescent material and application thereof | 常州大学 | 2025-05-02 | — | — | CN | disclosed |
| WO-2025066105-A1 | POLYMER, PREPARATION METHOD THEREFOR, RETARDER, AND OIL WELL CEMENT SLURRY | 中国石油天然气集团有限公司 | 2025-04-03 | — | — | WO | disclosed |
| CN-119708346-A | Polymer, preparation method thereof, retarder and oil well cement paste | 中国石油天然气集团有限公司 | 2025-03-28 | — | — | CN | disclosed |
| CN-113330096-B | Use of substituted or unsubstituted polycyclic aromatic compounds for high resolution microscopy | 马克斯·普朗克索赔科学公司 | 2024-05-31 | — | — | CN | disclosed |
| CN-114409679-B | Target membrane small molecule and preparation method and application thereof | 南京邮电大学 | 2024-01-16 | — | — | CN | disclosed |
| US-6831093-B2 | For selectively modulating the activation, repression, agonism and antagonism effects of the glucocorticoid receptor in a patient; for therapy and prophylaxis of obesity, diabetes, depression, neurodegeneration or an inflammatory disease | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA | 2004-12-14 | — | — | US | disclosed |
| EP-1467730-A1 | NON-STEROIDAL LIGANDS FOR THE GLUCOCORTICOID RECEPTOR, COMPOSITIONS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2004-10-20 | — | — | EP | disclosed |
| US-20040072681-A1 | Solid catalyst component for olefin polymerization and catalyst | TOHO TITANIUM CO., LTD. (JP) | 2004-04-15 | — | — | US | disclosed |
| US-20030176478-A1 | Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof | NIH-DEITR | 2003-09-18 | — | — | US | disclosed |
| WO-2003061651-A1 | NON-STEROIDAL LIGANDS FOR THE GLUCOCORTICOID RECEPTOR, COMPOSITIONS AND USES THEREOF | THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) | 2003-07-31 | — | — | WO | disclosed |
| EP-1260524-A1 | SOLID CATALYST COMPONENT FOR OLEFIN POLYMERIZATION AND CATALYST | Toho Titanium Co., Ltd. (JP) | 2002-11-27 | — | — | EP | disclosed |
| US-5087548-A | POSITIVE TYPE RADIATION-SENSITIVE RESIN COMPOSITION | JAPAN SYNTHETIC RUBBER CO., INC. (JP) | 1992-02-11 | — | — | US | disclosed |
| EP-0227487-A2 | Positive type radiation-sensitive resin composition | JAPAN SYNTHETIC RUBBER CO., LTD. (JP) | 1987-07-01 | — | — | EP | disclosed |
| US-3987109-A | POLYMERIZATION OF POLYFUNCTIONAL PHENOLS | UNIVERSAL OIL PRODUCTS COMPANY (US) | 1976-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030176478-A1 | Non-steroidal ligands for the glucocorticoid receptor, compositions and uses thereof | NR3C1, NR3C2, GCGR | TDP1 4121/4885CYP3A4 2531/4885TSHR 297/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.